Can slight variations in lab environments affect the malaria-causing parasite (Plasmodium) and its tolerance to anti-malarial drugs? Griffith University’s Sandra Duffy believes it’s possible.
Griffith University scientists have helped discover new compounds which could help block the transmission of the deadly disease malaria. A team of Griffith researchers has found a novel class of compounds, the hexahydro quinoline (HHQ), with potent activity against the parasite stages responsible for the clinical symptoms of malaria and its transmission to mosquitoes.
Scientistsfrom Griffith Universityhave contributed to a breakthrough identifying and characterising a potent agent that thwarts drug resistance in the parasite...
Medicines for Malaria Venture (MMV) estimates billions of people, especially children and pregnant women, are at risk of malaria in...
